awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q24800075-8BE31CFD-7579-4A49-B194-E1A1D47DF3E8
Q24800075-8BE31CFD-7579-4A49-B194-E1A1D47DF3E8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q24800075-8BE31CFD-7579-4A49-B194-E1A1D47DF3E8
Rivastigmine: an open-label, observational study of safety and effectiveness in treating patients with Alzheimer's disease for up to 5 years
P2860
Q24800075-8BE31CFD-7579-4A49-B194-E1A1D47DF3E8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q24800075-8BE31CFD-7579-4A49-B194-E1A1D47DF3E8
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
d57de8d3c347463ec4d3f9c56bc6370adc992937
P2860
Cholinesterase inhibitor treatment alters the natural history of Alzheimer's disease.